CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback